Projects per year
Personal profile
Biography
Mark A Febbraio
Professor Mark Febbraio is a Senior Principal Research Fellow of the NHMRC, and the Head of the Cellular and Molecular Metabolism Laboratory within the Drug Discovery Program at Monash Institute of Pharmaceutical Sciences, Monash University Australia. He is also the CSO of N-Gene Research Laboratories Inc., a USA based Biotechnology Company and the Founder and CSO of the recently incorporated company Kinomedica. His research is focussed on understanding mechanisms associated with exercise, obesity, type 2 diabetes and cancer and his aim is to develop novel drugs to treat lifestyle related diseases. He has authored over 260 peer reviewed papers in leading journals, has over 35,000 career citations and an H factor of 105. He has won prizes at international, national and institutional levels including the A K McIntyre Prize for significant contributions to Australian Physiological Science (1999), the ESA/ADS Joint Plenary Lecture (2009), the Sandford Skinner Oration from the University of Melbourne (2011), Eureka Scientific Prize Finalist (2013) and the Kellion Award for the Australian Diabetes Society (2017).
Research area keywords
- Cell Metabolism
- Diabetes
- Cancer Biology
- Exercise physiology
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
NAFLD, NASH and Hepatocellular carcinoma: Mechanisms & Potential Treatments
Febbraio, M., Karin, M. & Shackel, N.
1/07/19 → 31/12/20
Project: Research
The designer cytokine IC7: a novel therapy for the treatment of type 2 Diabetes
Febbraio, M. & Rose-John, S.
1/02/19 → 31/12/22
Project: Research
Development of novel therapies to treat obesity related metabolic diseases
1/01/21 → 31/12/25
Project: Research
Identification of novel secretory factors from the heart as new targets for metabolic disease
McMullen, J., Febbraio, M. & White, M. Y.
1/01/17 → 31/12/19
Project: Research
Research Output
Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes
Davey, J. R., Estevez, E., Thomson, R. E., Whitham, M., Watt, K. I., Hagg, A., Qian, H., Henstridge, D. C., Ludlow, H., Hedger, M. P., McGee, S. L., Coughlan, M. T., Febbraio, M. A. & Gregorevic, P., Apr 2020, In : The FASEB Journal. 34, 4, p. 5697-5714 18 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Sex-specific adipose tissue imprinting of regulatory T cells
Vasanthakumar, A., Chisanga, D., Blume, J., Gloury, R., Britt, K., Henstridge, D. C., Zhan, Y., Torres, S. V., Liene, S., Collins, N., Cao, E., Sidwell, T., Li, C., Spallanzani, R. G., Liao, Y., Beavis, P. A., Gebhardt, T., Trevaskis, N., Nutt, S. L., Zajac, J. D. & 5 others, , 26 Mar 2020, In : Nature. 579, 7800, p. 581–585+ 29 p.Research output: Contribution to journal › Article › Research › peer-review
3
Citations
(Scopus)
Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice
Whitham, M., Pal, M., Petzold, T., Hjorth, M., Egan, C. L., Brunner, J. S., Estevez, E., Iliades, P., Zivanovic, B., Reibe, S., Hughes, W. E., Findeisen, M., Hidalgo, J. & Febbraio, M. A., 30 Sep 2019, In : American Journal of Physiology - Endocrinology and Metabolism. 317, 4, p. E597-E604 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Can microbes increase exercise performance in athletes?
Turpin-Nolan, S. M., Joyner, M. J. & Febbraio, M. A., 1 Nov 2019, In : Nature Reviews Endocrinology. 15, 11, p. 629-630 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Metabolic control and sex: A focus on inflammatory-linked mediators
Henstridge, D. C., Abildgaard, J., Lindegaard, B. & Febbraio, M. A., 28 Feb 2019, In : British Journal of Pharmacology. 176, 21, p. 4193-4207 15 p.Research output: Contribution to journal › Review Article › Research › peer-review
6
Citations
(Scopus)